Medicamen Organics LTD

Medicamen Organics Ltd (MEDIORG) is a micro-cap Healthcare company valued at ₹40 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Medicamen Organics Ltd last traded at ₹26.75, unchanged on the day.

Recent developments

On 2026-06-30, promoter holding fell by 4.84 percentage points to 54.89%, signaling a reduction in ownership. Domestic institutional holding dropped to 0.00% from 1.64% in the previous quarter, indicating a withdrawal of investment.

Financial performance

The company's business is deteriorating, with annual revenue falling 40.7% to ₹23 crore and annual net profit swinging to a loss of ₹4 crore from a profit of ₹4 crore. The latest quarter shows a sharp decline, with revenue dropping 77.8% to ₹5 crore and net profit turning to a loss of ₹6 crore from a profit of ₹3 crore.

Valuation multiples

A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 0.98 times book value.

Things to watch

The company reported a net loss of ₹4 crore in its latest financial year, with net profit margin at -17.8% and return on equity at -14.0%. The stock is 35.4% below its 52-week high, and revenue has declined for five consecutive years, with a 2.0% annual decline over five years.

Where it stands

Medicamen Organics Ltd ended its latest financial year with a net loss of ₹4 crore, and the stock is 35.4% below its 52-week high. The most significant movement was the sharp drop in revenue and net profit in the latest quarter, with revenue falling 77.8% and net profit turning to a loss of ₹6 crore.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.